Protein Sequencing Market Scope
Protein sequencing refers to the process of deciding the amino acid sequence of all or part of proteins or peptides. There are two direct methods of protein sequencing such as mass spectrometry and Edman degradation in that mass spectrometry is widely used for protein sequencing. Increasing demand for protein biomarkers in the drug development process is trending in the protein sequencing market.
The market study is being classified by Type (Reagents & Consumables, Instrument, Analysis Products, Protein Sequencing Service and Others), by Application (Biotherapeutics and Genetic Engineering) and major geographies with country level break-up.
Research Analyst at AMA predicts that United States Players will contribute to the maximum growth of Global Protein Sequencing market throughout the predicted period.
Agilent Technologies (United States), Thermo Fisher Scientific, Inc. (United States), SGS S.A. (Switzerland), Shimadzu Corporation (Japan), Waters Corporation (United States), Charles River Laboratories (United States), Bioinformatics Solutions (Canada), Proteome Factory (Germany) and Rapid Novor (Canada) are some of the key players profiled in the study. Additionally, the Players which are also part of the research are Selvita (Poland).
AdvanceMarketAnalytics has segmented the market of Global Protein Sequencing market by Type, Application and Region.
On the basis of geography, the market of Protein Sequencing has been segmented into South America (Brazil, Argentina, Rest of South America), Asia Pacific (China, Japan, India, South Korea, Taiwan, Australia, Rest of Asia-Pacific), Europe (Germany, France, Italy, United Kingdom, Netherlands, Rest of Europe), MEA (Middle East, Africa), North America (United States, Canada, Mexico).
Market Leaders and their expansionary development strategies
In Jan 2019 , Shimadzu Medical Systems USA, a subsidiary of Shimadzu Corporation acquired Core Medical Imaging, Inc.
In June 2018, Shimadzu and Protein Metrics Inc. announced a co-marketing agreement for the use of Byos with Shimadzu Q-TOF technology. The co-marketing agreement combines Shimadzus latest Q-TOF technology with Protein Metrics software, which automates biotherapeutic characterization workflows.
- Increasing Demand for Protein Biomarkers in the Drug Development Process
- Rising drug development activities by biotechnology and pharmaceutical companies in various developing and developed regions
- Growth in the Demand for Protein Sequencing technique to Recognize Novel Peptides in Human Antibodies
- Technological Advancements for the Identification of Isobaric Residues in Protein Sequences
- Rising Funding for Proteomic Research by Public and Private Institutes
- A Requirement of Expensive Equipment
- Need for Skilled Researchers Professionals
Key Target AudienceResearch and Development Organisation, End-User Industry, Potential Investors and Government Bodies
Customization available in this Study:The Study can be customized to meet your requirements. Please connect with our representative, who will ensure you get a report that suits your needs.
Data related to EXIM [Export- Import], production & consumption by country or regional level break-up can be provided based on client request**
** Confirmation on availability of data would be informed prior purchase